简介 联系方式 相互作用: 118 620
根据名称进行药物检索

Paliperidone injection与网管系统

Paliperidone injection与网管系统安全配伍检测的结果。

检测结果:
Paliperidone injection <> 网管系统
现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

中心的多巴胺能阻断作用的神经抑制剂可以沉淀物或加剧一个潜在的致命症状的复杂称为精神病的恶性综合症(網管系統)。 网络管理系统是观察到的最常见的时高效剂等氟哌啶醇肌内给予，但是可能发生的任何神经抑制剂给予任何长度的时间。 临床表现形式的网络管理系统包括次高烧、肌肉的刚性，精神状态改变和自主的不稳定(不规则的脉冲或血压、心动过速、发汗解表和心脏的心律失常). 额外的标志可以包括升高的肌酸磷酸激酶,肌紅蛋白尿和急性肾功能衰竭。 神经抑制剂不应给予患者活动的网络管理系统，并应立即停止，如果目前正在给予这样的病人。 在患者病历史的网络管理系统，引入或重新引进的神经抑制剂应当仔细考虑，因为网络管理系统可能会再次出现。

来源
  • Anderson ES, Powers PS "Neuroleptic malignant syndrome associated with clozapine use." J Clin Psychiatry 52 (1991): 102-4
  • Sharma R, Trappler B, Ng YK, Leeman CP "Risperidone-induced neutroleptic malignant syndrome." Ann Pharmacother 30 (1996): 775-8
  • "Product Information. Haldol (haloperidol)." McNeil Pharmaceutical, Raritan, NJ.
  • Hermesh H, Sirota P, Eviatar J "Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine." Biol Psychiatry 25 (1989): 962-5
  • Najara JE, Enikeev ID "Risperidone and neuroleptic malignant syndrome: a case report." J Clin Psychiatry 56 (1995): 534-5
  • Tarsy D "Risperidone and neuroleptic malignant syndrome." JAMA 275 (1996): 446
  • Levenson JL "Neuroleptic malignant syndrome after the initiation of olanzapine." J Clin Psychopharmacol 19 (1999): 477-8
  • Dave M "Two cases of risperidone-induced neuroleptic malignant syndrome." Am J Psychiatry 152 (1995): 1233-4
  • Chong LS, Abbott PM "Neuroleptic malignant syndrome secondary to loxapine." Br J Psychiatry 159 (1991): 572-3
  • Burkhard PR, Vingerhoets FJG "Olanzapine induced neuroleptic malignant syndrome." Arch Gen Psychiat 56 (1999): 101-2
  • "Product Information. Clozaril (clozapine)." Novartis Pharmaceuticals, East Hanover, NJ.
  • Nemecek D "Atropism may precipitate neuroleptic malignant syndrome during treatment with clozapine." Am J Psychiatry 150 (1993): 1561
  • Aisen PS, Lawlor BA "Neuroleptic malignant syndrome induced by low-dose haloperidol." Am J Psychiatry 149 (1992): 844
  • Nyfort-Hansen K, Alderman CP "Possible neuroleptic malignant syndrome associated with olanzapine." Ann Pharmacother 34 (2000): 667
  • "Product Information. Loxitane C Oral Concentrate (loxapine)" Watson Laboratories Inc, Corona, CA.
  • Singer S, Richards C, Boland RJ "Two cases of risperidone-induced neuroleptic malignant syndrome." Am J Psychiatry 152 (1995): 1234
  • "Product Information. Risperdal (risperidone)." Janssen Pharmaceutica, Titusville, NJ.
  • "Product Information. Abilify (aripiprazole)." Bristol-Myers Squibb, Princeton, NJ.
  • "Product Information. Zyprexa (olanzapine)." Lilly, Eli and Company, Indianapolis, IN.
  • Levitt AJ, Midha R, Craven JL "Neuroleptic malignant syndrome with intravenous haloperidol." Can J Psychiatry 35 (1990): 789
  • Ewert AL, Kloek J, Wells B, Phelps S "Neuroleptic malignant syndrome associated with loxapine" J Clin Psychiatry 44 (1983): 37-8
  • Webster P, Wijeratne C "Risperidone-induced neuroleptic malignant syndrome." Lancet 344 (1994): 1228-9
  • "Product Information. Orap Tablets (pimozide)." Gate Pharmaceuticals, Sellersville, PA.
  • "Product Information. Moban (molindone)." Gate Pharmaceuticals, Sellersville, PA.
  • Kern JL, Cernek PK "Delayed risperidone-induced malignant syndrome." Ann Pharmacother 30 (1996): 300
  • Ryken TC, Merrell AN "Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism." West J Med 151 (1989): 326-8
  • Moltz DA, Coeytaux RR "Case report: Possible neuroleptic malignant syndrome associated with olanzapine." J Clin Psychopharmacol 18 (1998): 485-6
  • Gleason PP, Conigliaro RL "Neuroleptic malignant syndrome with risperidone." Pharmacotherapy 17 (1997): 617-21
  • Caroff SN "The neuroleptic malignant syndrome." J Clin Psychiatry 41 (1980): 79-83
  • Raitasuo V, Vataja R, Elomaa E "Risperidone-induced neuroleptic malignant syndrome in young patient." Lancet 344 (1994): 1705
  • "Product Information. Navane (thiothixene)." Roerig Division, New York, NY.
  • Campellone JV, Mccluskey LF, Greenspan D "Fatal outcome from neuroleptic malignant syndrome associated with clozapine." Neuropsychiatry Neuropsychol Behav Neurol 8 (1995): 70-3
  • DasGupta K, Young A "Clozapine-induced neuroleptic malignant syndrome." J Clin Psychiatry 52 (1991): 105-7
  • Johnson V, Bruxner G "Neuroleptic malignant syndrome associated with olanzapine." Aust N Z J Psychiat 32 (1998): 884-6
  • Margolese HC, Chouinard G "Olanzapine-induced neuroleptic malignant syndrome with mental retardation." Am J Psychiat 156 (1999): 1115-6
  • SierraBiddle D, Herran A, DiezAja S, GonzalezMata JM, Vidal E, DiezManrique F, VazquezBarquero JL "Neuroleptic malignant syndrome and olanzapine." J Clin Psychopharmacol 20 (2000): 704-5
  • Miller DD, Sharafuddin MJ, Kathol RG "A case of clozapine-induced neuroleptic malignant syndrome." J Clin Psychiatry 52 (1991): 99-101
  • "Product Information. Seroquel (quetiapine)." Zeneca Pharmaceuticals, Wilmington, DE.
  • "Product Information. Geodon (ziprasidone)." Pfizer US Pharmaceuticals, New York, NY.
  • Padgett R, Lipman E "Use of neuroleptics after an episode of neuroleptic malignant syndrome" Can J Psychiatry 34 (1989): 323-5
Paliperidone injection

非专利名称: paliperidone

品牌: Invega, Invega Sustenna, Invega Trinza

同义词: Paliperidone

Paliperidone injection是什么？
其他的药物 删除
公认药物相互作用的清单
DiseDoc 和平
与食物，生活方式相互作用
  1. Paliperidone injection
药物互相作用
  1. Paliperidone injection
我们使用Cookie来优化网站性能。通过继续浏览这个网站,你同意使用Cookie。 同意